palmitoylcarnitine has been researched along with 1-(5-isoquinolinesulfonyl)-2-methylpiperazine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 5 (83.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergstrand, H; Karabelas, K; Lundquist, B; Michelsen, P | 1 |
Butler, AP; Mar, PK; McDonald, FF; Ramsay, RL | 1 |
Abe, K; Katoh, N; Matsuno, K; Miyazaki, T; Sakurada, K; Tanaka, M; Uehara, Y | 1 |
Buzilã, L; Laky, M; Moraru, II; Popescu, LM; Stãnescu, T | 1 |
Inui, N; Semba, M | 1 |
Arese, P; Bussolino, F; Fischer, E; Kazatchkine, MD; Turrini, F | 1 |
6 other study(ies) available for palmitoylcarnitine and 1-(5-isoquinolinesulfonyl)-2-methylpiperazine
Article | Year |
---|---|
Modulation of human basophil histamine release by protein kinase C inhibitors differs with secretagogue and with inhibitor.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Basophils; Calcimycin; Glyceryl Ethers; Histamine Release; Humans; Indoles; Isoquinolines; Maleimides; Mannitol; Palmitoylcarnitine; Piperazines; Polymyxin B; Protein Kinase C; Sphingosine; Staurosporine; Sulfonamides; Tetradecanoylphorbol Acetate | 1992 |
Involvement of protein kinase C in the regulation of ornithine decarboxylase mRNA by phorbol esters in rat hepatoma cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Diglycerides; Down-Regulation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Isoquinolines; Liver Neoplasms, Experimental; Ornithine Decarboxylase; Palmitoylcarnitine; Phorbol 12,13-Dibutyrate; Phorbol Esters; Piperazines; Protein Kinase C; Protein Kinase Inhibitors; Rats; RNA, Messenger; Tetradecanoylphorbol Acetate; Type C Phospholipases | 1991 |
Phosphorylation of coagulation factor II by phospholipid/Ca(2+)-dependent protein kinase (protein kinase C).
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amino Acids; Animals; Cattle; Gossypol; Humans; Isoquinolines; Kinetics; Palmitoylcarnitine; Phosphorylation; Piperazines; Protein Kinase C; Prothrombin; Spleen; Swine; Thrombin; Trifluoperazine | 1991 |
Protein kinase C controls Fc gamma receptor-mediated endocytosis in human neutrophils.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Antigens, Differentiation; Cells, Cultured; Endocytosis; Humans; Immunoglobulin G; Isoquinolines; Kinetics; Neutrophils; Palmitoylcarnitine; Piperazines; Protein Kinase C; Receptors, Fc; Receptors, IgG; Signal Transduction; Sphingosine; Tamoxifen | 1990 |
Effects of activators and inhibitors of protein kinase C on two-stage transformation in BALB/3T3 cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Animals; Cell Line; Cell Transformation, Neoplastic; Cocarcinogenesis; Diglycerides; Drug Antagonism; Enzyme Activation; Glycerides; Isoquinolines; Methylcholanthrene; Mice; Palmitoylcarnitine; Piperazines; Protein Kinase C; Staurosporine; Tetradecanoylphorbol Acetate | 1990 |
Platelet-activating factor enhances complement-dependent phagocytosis of diamide-treated erythrocytes by human monocytes through activation of protein kinase C and phosphorylation of complement receptor type one (CR1).
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Azo Compounds; Cell Adhesion; Complement System Proteins; Diamide; Enzyme Activation; Erythrocytes; Humans; In Vitro Techniques; Isoquinolines; Kinetics; Monocytes; Palmitoylcarnitine; Phagocytosis; Phosphorylation; Piperazines; Platelet Activating Factor; Protein Kinase C; Receptors, Complement; Sphingosine; Staurosporine; Structure-Activity Relationship | 1989 |